Journals / Türk Kardiyoloji Derneği Arşivi / 2008 / Cilt: 36 - Sayı: 8

A rare cause of pulmonary hypertension: Pulmonary Langerhans cell granulomatosis

Pulmoner hipertansiyonunun nadir bir nedeni: Pulmoner Langerhans hücreli granülomatozis

Pages
558–561
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Based on these findings, medical treatment was scheduled for the patient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary Langerhans cell granulomatosis (PLCG) is a smoking-related interstitial lung disease characterized by hyperinflation and/or obstructive pulmonary disease.
📊
Key Findings & Data:A 24-year-old male patient who had been receiving diltiazem and corticosteroid treatment with the diagnosis of PLCG for four years was examined by the cardiology clinic due to dyspnea and deterioration in his functional capacity.
💡
Conclusion & Impact:Based on these findings, medical treatment was scheduled for the patient.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pulmonary Langerhans cell granulomatosis (PLCG) is a smoking-related interstitial lung disease characterized by hyperinflation and/or obstructive pulmonary disease. Pulmonary hypertension is a late complication of advanced pulmonary disease and often portends a poor prognosis. A 24-year-old male patient who had been receiving diltiazem and corticosteroid treatment with the diagnosis of PLCG for four years was examined by the cardiology clinic due to dyspnea and deterioration in his functional capacity. He was in New York Heart Association class III. The electrocardiogram showed sinus rhythm and right bundle branch block. Systolic pulmonary artery pressure (SPAP) was estimated as 80 mmHg with continuous-wave Doppler echocardiography. During right heart catheterization, SPAP was 70 mmHg and the mean pulmonary artery pressure (MPAP) was 44 mmHg. Vascular pulmonary reactivity test with adenosine did not result in a significant change in MPAP. Based on these findings, medical treatment was scheduled for the patient.

Özet

Pulmoner Langerhans hücreli granülomatozis (PLHG), sigara içme ile ilişkili, hiperinflasyon ve/veya tıkayıcı akciğer hastalığı ile seyreden interstisyel bir hastalıktır. Pulmoner hipertansiyon ilerlemiş akciğer hastalığında görülen geç bir komplikasyondur ve sıklıkla kötü prognoz göstergesidir. Dört yıldır PLHG tanısıyla diltiazem ve kortikosteroid tedavisi gören 24 yaşında erkek hasta, nefes darlığı ve fonksiyonel kapasitesinin kötüleşmesi nedeniyle kardiyoloji kliniğinde incelendi. New York Kalp Birliği fonksiyonel sınıfı 3 olan hastanın elektrokardiyografisinde sinüs ritmi ve sağ dal bloku izlendi. Sürekli dalga Doppler ekokardiyografi ile sistolik pulmoner arter basıncı (SPAB) 80 mmHg olarak hesaplandı. Yapılan sağ kalp kateterizasyonunda SPAB 70 mmHg, ortalama pulmoner arter basıncı (OPAB) 44 mmHg ölçüldü. Vazodilatör tedaviye yanıtı değerlendirmek amacıyla adenozin ile yapılan pulmoner reaktivite testinde OPAB’de önemli değişim izlenmedi. Bu sonuçlara dayanarak, hastaya medikal tedavi planlandı.

🔖

Cite This Article

GÜRAY, Ü., ASTAN, R., GÜCÜK, E., GÜRAY, Y. (2022). A rare cause of pulmonary hypertension: Pulmonary Langerhans cell granulomatosis. Türk Kardiyoloji Derneği Arşivi, Cilt: 36 - Sayı: 8, 558–561. https://ajindex.com/articles/633554

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hance AJ, Cadranel J, Soler P, Basset F. Pulmonary and extrapulmonary Langerhans cell granulomatosis (histio-cytosis X). Semin Respir Med 1988;9:349-68
  2. Hamada K, Teramoto S, Narita N, Yamada E, Teramoto K, Kobzik L. Pulmonary veno-occlusive disease in pulmonary Langerhans’ cell granulomatosis. Eur Respir J 2000;15:421-3
  3. Harari S, Brenot F, Barberis M, Simmoneau G. Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension. Chest 1997;111:1142-4
  4. Fartoukh M, Humbert M, Capron F, Maitre S, Parent F, Le Gall C, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000;161:216-23
  5. Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25:2243-78
  6. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans’-cell histiocytosis in adults. N Engl J Med 2002;346:484-90
  7. Ryu JH, Krowka MJ, Pellikka PA, Swanson KL, McGoon MD. Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc 2007;82:342-50
  8. Von Essen S, West W, Sitorius M, Rennard SI. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 1990;98:765-7
  9. Mogulkoc N, Veral A, Bishop PW, Bayindir U, Pickering CA, Egan JJ. Pulmonary Langerhans’ cell histiocytosis: radiologic resolution following smoking cessation. Chest 1999;115:1452-5
  10. Tazi A, Montcelly L, Bergeron A, Valeyre D, Battesti JP, Hance AJ. Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 1998;157:2007-10
  11. Schonfeld N, Frank W, Wenig S, Uhrmeister P, Allica E, Preussler H, et al. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 1993;60:38-44
  12. Benyounes B, Crestani B, Couvelard A, Vissuzaine C, Aubier M. Steroid-responsive pulmonary hypertension in a patient with Langerhans’ cell granulomatosis (histiocytosis X). Chest 1996;110:284-6
  13. Bencic D, Smojver S, Boras Z, Potocki K, Batinic D. Progressive form of pulmonary Langenharns’ cell histiocytosis in a female adult non-smoker. Respirology 2003;8:525-8
  14. Liang GC, Granston AS. Complete remission of multicentric reticulohistiocytosis with combin